1. Home
  2. ABR vs ANAB Comparison

ABR vs ANAB Comparison

Compare ABR & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$7.76

Market Cap

1.6B

Sector

Real Estate

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$47.57

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
ANAB
Founded
2003
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
ABR
ANAB
Price
$7.76
$47.57
Analyst Decision
Hold
Buy
Analyst Count
6
12
Target Price
$10.20
$60.18
AVG Volume (30 Days)
3.5M
482.0K
Earning Date
02-20-2026
02-26-2026
Dividend Yield
15.50%
N/A
EPS Growth
N/A
N/A
EPS
0.80
N/A
Revenue
$552,909,000.00
$169,467,000.00
Revenue This Year
N/A
$135.51
Revenue Next Year
N/A
N/A
P/E Ratio
$9.72
N/A
Revenue Growth
N/A
196.42
52 Week Low
$7.58
$12.21
52 Week High
$14.33
$52.47

Technical Indicators

Market Signals
Indicator
ABR
ANAB
Relative Strength Index (RSI) 39.98 54.75
Support Level $7.69 $44.25
Resistance Level $8.24 $48.53
Average True Range (ATR) 0.28 2.96
MACD 0.05 -0.20
Stochastic Oscillator 19.70 66.35

Price Performance

Historical Comparison
ABR
ANAB

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: